documents: FDA-2009-D-0095-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-D-0095-0001 | FDA | FDA-2009-D-0095 | Draft Guidance for Industry on the Clinical Pharmacology Section of Labeling for Human Prescription Drug and Biological Products--Content and Format | Notice | Notice of Availability | 2009-03-03T05:00:00Z | 2009 | 3 | 2009-03-03T05:00:00Z | 2009-06-02T03:59:59Z | 2016-11-18T14:37:51Z | E9-04372 | 0 | 0 | 09000064808e801c |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref